SCHEMBL14434166

SCHEMBL14434166

Nc1ccc(C2(c3ccccc3)OCCO2)cc1C(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.49
CYP26A1 O43174 4/20 0.46
RXRA P19793 3/20 0.46
CYP26B1 Q9NR63 3/20 0.46
RXRB P28702 2/20 0.46
CHEK2 O96017 1/20 0.44
LMNA P02545 2/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
CYP3A4 P08684 1/20 0.39
ALDH1A1 P00352 1/20 0.39
RXRG P48443 1/20 0.39
CYP2C8 P10632 1/20 0.39
CYP2C9 P11712 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
CASP1 P29466 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4382647 0.92 MAPT (0.49) MAPTPOLBGAACYP26A1RXRA
SCHEMBL10839815 0.84 MAPT (0.51) MAPTPOLBGAALMNATSHR
SCHEMBL4369358 0.82 ALOX15 (0.44) MAPTGAACYP26A1RXRACYP26B1
SCHEMBL5780967 0.80 MAPT (0.42) MAPTPOLBCYP26A1RXRACYP26B1
SCHEMBL12022155 0.80 MAPT (0.51) MAPTPOLBGAACYP26A1RXRA
SCHEMBL11700084 0.79 CYP26A1 (0.41) CYP26A1RXRACYP26B1RXRBCHEK2
SCHEMBL5518160 0.77 NPC1 (0.44) MAPTPOLBALDH1A1CYP2C8SMN1; SMN2
SCHEMBL11699934 0.72 MAPT (0.45) MAPTPOLBCYP26A1RXRACYP26B1
SCHEMBL4385349 0.71 MAPT (0.53) MAPTPOLBGAALMNATSHR
SCHEMBL1256099 0.71 CHEK2 (0.39) CYP26A1RXRACYP26B1RXRBCHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7253183-B2 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation JANSSEN PHARMACEUTICA N.V. (BE) 2007-08-07 US disclosed